Doseology Sciences Inc. (CSE:MOOD)

Market Cap	4.41M +400.7%
Revenue (ttm)	n/a
Net Income	n/a
EPS	n/a
Shares Out	8.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	8,334
Open	0.5500
Previous Close	0.5000
Day's Range	0.5500 - 0.5500
52-Week Range	0.1500 - 1.9000
Beta	-2.74
RSI	46.32
Earnings Date	n/a

About Doseology Sciences

Doseology Sciences Inc., through its subsidiary, Dose Labs Inc., engages in the research, development, and sale of functional mushroom products with a focus on mental health research in Canada. The company also offers medicinal mushroom products, including tinctures. It sells its products online through doseology.com and e-commerce platforms, as well as through various retail chains and distributors. The company was formerly known as Pcybin Therapeutic Inc. and changed its name to Doseology Sciences Inc. in January 2020. Doseology Sciences Inc....

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: MOOD